Primary Care Diabetes
Volume 3, Issue 1 , Pages 57-59, February 2009

The new rosiglitazone story: Its place today in Type 2 diabetes management

Cardiovascular and Metabolic Centre of Excellence, GlaxoSmithKline, Stockley Park West, Uxbridge, Middx UB11 1BT, United Kingdom

Received 20 October 2008; accepted 31 January 2009. published online 09 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1751-9918(09)00005-9

doi:10.1016/j.pcd.2009.01.002

Primary Care Diabetes
Volume 3, Issue 1 , Pages 57-59, February 2009

Article Tools